Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
Intensity Therapeutics upsizes proposed IPO to $15M from $8M (INTS) Finances May 19, 2023 Andrey Tolkachev Oncology drug developer Depth Therapeutics (NASDAQ:INTS) has upsized its proposed preliminary public providing to $15M from $8M. The…
